Novartis generics subsidiary Sandoz made history ahead of the weekend after getting approval in the US for Zarxio, the first biosimilar cleared by the FDA. Zarxio (filgrastim-sndz) is a biosimilar ...
Patients in the US with the ultra-rare disease WHIM syndrome now have their first approved treatment, after X4 Pharma’s Xolremdi was given a green light by the FDA. Oral CXCR4 antagonist Xolremdi ...
Camber is expanding its launching four new generics. The company is releasing plerixafor injection, which is a generic for Mozobil. It is available in 24 mg/1.2 ml (20 mg/ml). Ple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results